Most of the R&D work on induced pluripotent stem cells has been done with skin tissue, but recently, investigators at the Whitehead Institute (Cambridge, MA) have reported using blood cells which they reprogrammed for pluripotency. Their technique involved inserting a gene “cassette.”  While the long-term potential of this could be in treating diseases like Parkinson’s, the immediate utility is in discovering how blood diseases arise.   MORE